Willow

Independence Blue Cross and The Colorectal Cancer Alliance Launch 45+ Reasons Campaign to Support Colorectal Cancer Prevention

Retrieved on: 
Tuesday, August 8, 2023
Survival rate, Independence Blue Cross, Perelman School of Medicine at the University of Pennsylvania, Partnership, University, Wellness, Health equity, Cancer, Large intestine, African Americans, Colorectal Cancer Alliance, Penn Medicine Rittenhouse, Black, Organization, Perelman Center for Advanced Medicine, Community Alliance, Incidence, Colorectal cancer, Development, MD, Pennsylvania Department of Aging, Risk, Salix Pharmaceuticals, Child, Colonoscopy, Cycle, Diversity, Radio, University of Pennsylvania Health System, Mortality, American Cancer Society, USPSTF, Willow, Pennsylvania Department of Health, Social media, Disease, Pharmaceutical industry, Mobile phone, Vaccine, Independence, Medicine

PHILADELPHIA, Aug. 8, 2023 /PRNewswire/ -- Independence Blue Cross (Independence) and the Colorectal Cancer Alliance (the Alliance) announced the launch of 45+ Reasons, a campaign to get more than 5,000 Black Philadelphians ages 45-75 screened for colorectal cancer to reduce the significantly higher incidence and mortality rates of Black Americans. The campaign supports the Cycles of Impact initiative launched by Independence and the Alliance in 2022.

Key Points: 
  • To ensure that the colorectal cancer prevention and screening messages reach those most at risk, the Alliance is launching a compelling new awareness campaign called 45+ Reasons.
  • The community engagement, social media, and advertising campaign aims to instill much-needed trust in the healthcare system with fact-based support for colorectal cancer as a preventable cancer.
  • One way we are addressing this is through this partnership with the Colorectal Cancer Alliance to reduce gaps in colorectal cancer screening rates among Black Philadelphians, who are disproportionately impacted by colorectal cancer."
  • "As the largest nonprofit organization solely committed to ending colorectal cancer, the Alliance is uniquely positioned to lead this bold health intervention," said Michael Sapienza, CEO of the Colorectal Cancer Alliance.

WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON AUGUST 9

Retrieved on: 
Wednesday, August 2, 2023
TSX, Willow, RSVP, WLLW, Conference, Cryptocurrency

SUNNYVALE, Calif., Aug. 2, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients announces that it will present at the upcoming Emerging Growth Conference August 8-9, 2023.

Key Points: 
  • SUNNYVALE, Calif., Aug. 2, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients announces that it will present at the upcoming Emerging Growth Conference August 8-9, 2023.
  • President and CEO Dr. Chris Savile will provide an update on Willow's business during a live virtual presentation at 2:55 p.m. Eastern Time on Wednesday, August 9.
  • RSVP: Please register here to ensure you are able to attend the conference and receive any updates on the company that are released.
  • If attendees are not able to join the live event on August 9, an archived webcast will also be available on the EmergingGrowth.com website and on the Emerging Growth YouTube Channel afterward.

Hillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors via Bispecific and ADC Antibodies and Biologics

Retrieved on: 
Monday, July 10, 2023
Bispecific monoclonal antibody, Monoclonal antibody, Antigen, Bausch Health, Therapy, HER3, Critical, HER2, Neoplasm, Salix Pharmaceuticals, Biotechnology, Trastuzumab, Cancer, Daiichi Sankyo, Bystander effect, Rutgers University, US, Acquisition, Patient, EGFR, Minotaur, Epitope, Spacecraft, PD-1, Sanofi, IND, Metastasis, Vaccine, Pharmaceutical industry, Amgen, Pharmacy, Chiesi Farmaceutici, Hillstream loach, Willow

BRIDGEWATER, N.J., July 10, 2023 (GLOBE NEWSWIRE) --  Hillstream BioPharma (Nasdaq: HILS) a biotechnology company developing innovative therapeutic candidates targeting drug resistant and devastating cancers that can make a difference in patients’ lives, today announced a strategic reprioritization of its pipeline and provided a corporate update. The strategic assessment took into account, the pipeline’s near-term value creation opportunity and other factors. Hillstream will focus its pipeline on advancing novel oncology assets with the greatest potential and strong competitive profiles to address unmet needs across multiple solid tumors, such as bispecific antibodies and ADCs targeting novel conformational epitopes on high value validated targets, HER2 and HER3, with a more potent Bystander Effect.

Key Points: 
  • Bispecific antibodies (BsAbs) refer to a diverse group of molecules that recognize distinct epitopes on two different antigens, such as HER2 and HER3.
  • HER2, an extensively studied and validated target, has multiple approved therapeutics for solid tumors.
  • Hillstream’s lead asset, HSB-3215 is designed as a bispecific humanized immunoglobulin containing two arms targeting the extracellular domains of HER2 and HER3.
  • “I am thrilled to join Hillstream and look forward to working alongside the team as we further our development programs.

Many urban waterways were once waste dumps. Restoration efforts have made great strides – but there's more to do to bring nature back

Retrieved on: 
Thursday, June 15, 2023
GPS, Food, Travel, Environmental protection, Life, Environment Protection Act, 1986, Tree, River, Australia Day, Monash University, Sewage, Melbourne Water, Nutrient, State government, Cosmetics, Electron, Plant, Pesticide, Animal, Soil, Time, Water, Slaughterhouse, Parasitism, City, Government, Bacteria, Endangered species, Health, Nitrogen, Phosphorus, Invertebrate, Death, Industrial waste, Farm, Wetland, Livestock, Road, Canal, Sewage treatment, Agriculture, Aquaculture, Willow, Darebin Creek, Wind, Oven, Brisbane River, NSW

Melbourne’s major river, the Maribyrnong, was full of waste from abattoirs, tanneries and factories.

Key Points: 
  • Melbourne’s major river, the Maribyrnong, was full of waste from abattoirs, tanneries and factories.
  • I live near Darebin Creek in Melbourne’s north, which was next to a tip and often polluted until cleanup efforts began in the 70s.
  • Here’s what the restoration of Darebin Creek shows us about the successes and challenges of bringing life back to our urban waterways.

Rivers or rubbish dumps?

    • European settlement had a big effect on creeks and rivers, we’ve often used them as convenient waste dumps.
    • Treating rivers as dumps can (unsurprisingly) damage or even wipe out the life in it.
    • Read more:
      A tale of 2 rivers: is it safer to swim in the Yarra in Victoria, or the Nepean in NSW?
    • The group spent decades removing weeds and rubbish and planting trees.
    • Rivers such as the Ovens and the Murray, and even the Yarra in places, are in poorer condition with low flows and high sediment and salt levels major issues.

How do we fully restore our city waterways?


    Native species reliant on our city waterways still face threats. These include:

How can we help bring life back?

    • If there’s a lesson in the restoration work done so far, it’s that we can’t expect life just to bounce back.
    • Join a local Waterwatch program to monitor river health, or join the national waterbug blitz to learn more about invertebrate life.

WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON JUNE 14

Retrieved on: 
Wednesday, June 7, 2023
Growth, TSX, RSVP, WLLW, Conference, Willow

MOUNTAIN VIEW, Calif., June 7, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients announces that it has been invited to present at the Emerging Growth Conference on June 14.

Key Points: 
  • MOUNTAIN VIEW, Calif., June 7, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients announces that it has been invited to present at the Emerging Growth Conference on June 14.
  • President and CEO Dr. Chris Savile will participate in a live virtual presentation at 10:15 a.m. Eastern Time and provide an update on Willow's business.
  • RSVP: Please register here to ensure you are able to attend the conference and receive any updates on the company that are released.
  • If attendees are not able to join the live event on June 14, an archived webcast will also be available on the EmergingGrowth.com and on the Emerging Growth YouTube Channel afterward.

WILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR AGE-RELATED DISEASES

Retrieved on: 
Wednesday, May 31, 2023
TSX, Growth, Master service agreement, Partnership, API, Health, WLLW, Notifiable disease, MSA, Fine chemical, Willow

MOUNTAIN VIEW, Calif., May 31, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients announces execution of a Master Services Agreement (the "MSA") with an innovative biotech company focused on age-related diseases.

Key Points: 
  • MOUNTAIN VIEW, Calif., May 31, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable functional ingredients announces execution of a Master Services Agreement (the "MSA") with an innovative biotech company focused on age-related diseases.
  • Through this partnership, Willow will develop precision fermentation processes for a class of molecules with targets being developed as nutritional supplements for health and wellness and active pharmaceutical ingredients (APIs).
  • Willow will use its FutureGrown™ technology platform and yeast-strain engineering expertise with the goal of developing a strain and process for production of the partner's ingredients.
  • Due to the disruptive potential nature of its targeted product applications, the partner's name and target molecules are not being disclosed at this time.

KALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME FOR PRODUCTION OF AN ADVANCED BEVERAGE INGREDIENT

Retrieved on: 
Tuesday, May 23, 2023
Partnership, Food, Global R&D management, Master service agreement, Science, Nature, MSA, Willow Garage, TSX, WLLW, Willow, Fine chemical, Management

"We look forward to further evidencing our technological capabilities through what we believe will be a similarly successful outcome for this next program."

Key Points: 
  • "We look forward to further evidencing our technological capabilities through what we believe will be a similarly successful outcome for this next program."
  • Kalsec's projects focus on yeast, which, among other applications, is an ideal host for production of numerous ingredients for the food and beverage sector.
  • By working closely with their customers, the development team at Kalsec has identified multiple potential opportunities for collaboration and innovation in this space.
  • "We are excited to expand our partnership with Willow and leverage each party's significant domain expertise toward what we believe will be successful commercial-scale production in 2024."

WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2023 RESULTS

Retrieved on: 
Friday, May 12, 2023
Food, Bank statement, Sandhill, Active ingredient, CBG, The Company, SEDAR, Drug discovery, Protein engineering, TSX, Growth, WLLW, Biocatalysis, M3, Willow Springs Distilling Company, Willow, Fine chemical, Renewable energy, Cannabigerol

Willow's unaudited consolidated interim financial statements and related management's discussion and analysis for the quarter ended March 31, 2023 are available on SEDAR at www.sedar.com .

Key Points: 
  • Willow's unaudited consolidated interim financial statements and related management's discussion and analysis for the quarter ended March 31, 2023 are available on SEDAR at www.sedar.com .
  • On February 22, 2023, Willow announced the appointment of Jim Lalonde, Ph.D. as its newest independent member of the Company's Board of Directors, effective February 21, 2023.
  • Willow ended the quarter with strong liquidity, including approximately $10.5 million of cash as of March 31, 2023, with the Company's approved annual budget expected to be fully funded for 2023.
  • The Company reported revenue of $274,000 for the quarter compared to nil revenue for the first quarter of 2022.

Construction on Willow Oil Project in Alaska Underway, an Industrial Info News Alert

Retrieved on: 
Tuesday, May 9, 2023
Other Construction & Property, Oil, Gas, Manufacturing, Energy, Construction & Property, Other Manufacturing, Society of Environmental Journalists, White House, IIR, ConocoPhillips, Headache, U.S. Department of the Interior, Office of Inspector General, U.S. Department of Defense Strategy for Operating in Cyberspace, Friends, Haaland, GMI, Research, USD, Government, White, Pulse, Natural gas, Conoco, Interior, Federation, News, Whaling, Airline, Renewable energy, Willow

Researched by Industrial Info Resources-- Raising its guidance for full-year production, ConocoPhillips Company added that it started construction on the controversial Willow oil project in Alaska, some two months after plans were approved.

Key Points: 
  • Researched by Industrial Info Resources-- Raising its guidance for full-year production, ConocoPhillips Company added that it started construction on the controversial Willow oil project in Alaska, some two months after plans were approved.
  • Elsewhere, the company said it was pleased to have received a positive decision for its Willow oil project in Alaska, where it acquired oil and gas leases in the late 1990s.
  • The federal government signed off on Willow on March 13, though its scope was scaled down significantly.
  • Subscribers to Industrial Info's Global Market Intelligence (GMI) Oil & Gas Production Project Database can click here for a list of Willow-related project reports and click here for the related plant profiles.

Willow Industries Expands Business Services with Launch of New Consulting Arm: Willow Scientific

Retrieved on: 
Tuesday, May 2, 2023
GMP, Atmosphere, Standard, Science, SOP, The Company, Soil, Water, Cannabis, Willow, Risk management, Fine chemical

DENVER, May 2, 2023 /PRNewswire/ -- Willow Industries, ("Willow" or "The Company") the leader in cannabis kill-step and decontamination technology, announced the launch of Willow Scientific, a new tiered suite of microbial consulting services that offers a proactive approach for long-term success by addressing and solving contamination at the source.

Key Points: 
  • Willow Scientific to Offer New, Tiered Consulting Services to Help Cannabis Businesses Identify and Mitigate Contamination at the Source
    DENVER, May 2, 2023 /PRNewswire/ -- Willow Industries , ("Willow" or "The Company") the leader in cannabis kill-step and decontamination technology, announced the launch of Willow Scientific , a new tiered suite of microbial consulting services that offers a proactive approach for long-term success by addressing and solving contamination at the source.
  • The new services are an expansion of the microbial support that businesses leasing WillowPure technology currently receive.
  • "The launch of Willow Scientific significantly expands our microbial assessment services, and takes another meaningful step forward in opening up these services to the industry at large," said Jill Ellsworth, founder and CEO of Willow Industries.
  • Utilizing these services can help protect businesses from costly testing failures and recalls, and more importantly, help protect consumer safety.